TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia

Polymerase chain reaction-based screening of childhood acute lymphoblastic leukemia (ALL) samples showed that a TEL/AML 1 fusion transcript was detected in 27% of all cases, representing the most common known gene rearrangement in childhood cancer. The TEL/AML1 fusion results from a t(12;21)(p13;q22...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: McLean, Thomas W. (VerfasserIn) , Ringold, Sarah (VerfasserIn) , Neuberg, Donna (VerfasserIn) , Stegmaier, Kimberly (VerfasserIn) , Tantravahi, Ramana (VerfasserIn) , Ritz, Jerome (VerfasserIn) , Koeffler, H. Phillip (VerfasserIn) , Takeuchi, Seisho (VerfasserIn) , Janssen, Johannes W. G. (VerfasserIn) , Seriu, Taku (VerfasserIn) , Bartram, Claus R. (VerfasserIn) , Sallan, Stephen E. (VerfasserIn) , Gilliland, D. Gary (VerfasserIn) , Golub, Todd R. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 December 1996
In: Blood
Year: 1996, Jahrgang: 88, Heft: 11, Pages: 4252-4258
ISSN:1528-0020
DOI:10.1182/blood.V88.11.4252.4252
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.V88.11.4252.4252
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0006497120611703
Volltext
Verfasserangaben:Thomas W. McLean, Sarah Ringold, Donna Neuberg, Kimberly Stegmaier, Ramana Tantravahi, Jerome Ritz, H. Phillip Koeffler, Seisho Takeuchi, Johannes W. G. Janssen, Taku Seriu, Claus R. Bartram, Stephen E. Sallan, D. Gary Gilliland, Todd R. Golub
Beschreibung
Zusammenfassung:Polymerase chain reaction-based screening of childhood acute lymphoblastic leukemia (ALL) samples showed that a TEL/AML 1 fusion transcript was detected in 27% of all cases, representing the most common known gene rearrangement in childhood cancer. The TEL/AML1 fusion results from a t(12;21)(p13;q22) chromosomal translocation, but was undetectable at the routine cytogenetic level. TEL/AML1-positive patients had exclusively B-lineage ALL, and most patients were between the ages of 2 and 9 years at diagnosis. Only 3/89 (3.4%) adult ALL patients were TEL/AML 7-positive. Most importantly, TEL/AML 1-positive children had a significantly lower rate of relapse compared with TEL/AML 1-negative patients (0/22 ν 16/54, P = .004). Co-immunoprecipitation experiments demonstrated that TEL/AML-1 formed homodimers in vitro, and heterodimerized with the normal TEL protein when the two proteins were expressed together. The elucidation of the precise mechanism of transformation by TEL/AML1 and the role of TEL/AML1 testing in the treatment of childhood ALL will require additional studies.
Beschreibung:Elektronische Reproduktion der Druck-Ausgabe 14. Dezember 2020
Gesehen am 14.12.2023
Beschreibung:Online Resource
ISSN:1528-0020
DOI:10.1182/blood.V88.11.4252.4252